Stocks › CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CRL·NYSE·
United States·USD
United States·USD$304.96
-5.81 (-1.87%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CRLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CRL by members of U.S. Congress · 30 on record · 2 in the last 12 months
Whale Activity
Position changes in CRL reported for 2026-06-30 by 3 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed2
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 281.8K | $63.9M | — |
| Bridgewater Associates | 0 | $0 | closed |
| Two Sigma Investments, LP | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CRL insiders, by quarter · Form 4
Recent Insider Transactions
9,040 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Coleman GlennEVP & Chief Financial Officer | Purchase | +10 | $297.43 | $3K | Sep 30, 2026 | Form 4 ↗ |
| FOSTER JAMES CDirector · Director | Sale | −33.6K | $300.00 | $10.1M | Aug 25, 2026 | Form 4 ↗ |
| Parisotto Shannon MCEVP, Disc & Safety Assessment | Sale | −2,039 | $294.12 | $600K | Aug 19, 2026 | Form 4 ↗ |
| Andrews Nancy CDirector · Director | Sale | −573 | $285.24 | $163K | Aug 18, 2026 | Form 4 ↗ |
| Girshick BirgitChief Executive Officer · Director | Sale | −6,500 | $279.90 | $1.8M | Aug 11, 2026 | Form 4 ↗ |
| Parisotto Shannon MCEVP, Disc & Safety Assessment | Sale | −3,714 | $279.66 | $1.0M | Aug 11, 2026 | Form 4 ↗ |
| FOSTER JAMES CDirector · Director | Sale | −28.7K | $275.00 | $7.9M | Aug 10, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −901 | $260.63 | $235K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −810 | $261.45 | $212K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −736 | $258.53 | $190K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −620 | $263.94 | $164K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −482 | $265.17 | $128K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −404 | $258.53 | $104K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −213 | $262.37 | $56K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −1,274 | $259.07 | $330K | Aug 6, 2026 | Form 4 ↗ |
| Knell Michael GunnarSVP, Finance and CAO | Sale | −1,205 | $258.53 | $312K | Aug 6, 2026 | Form 4 ↗ |
| Creamer Victoria LEVP & Chief People Officer | Sale | −4,179 | $259.16 | $1.1M | Aug 6, 2026 | Form 4 ↗ |
| Parisotto Shannon MCEVP, Disc & Safety Assessment | Sale | −5,046 | $263.00 | $1.3M | Aug 5, 2026 | Form 4 ↗ |
| FOSTER JAMES CDirector · Director | Sale | −75.0K | $225.00 | $16.9M | Jun 29, 2026 | Form 4 ↗ |
| FOSTER JAMES CDirector | Gift | +10.0K | $0.00 | $0 | Jun 5, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CRL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| Fidelity Contrafund | 1.8M | $410.0M | 0.23% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.5M | $347.0M | 0.02% | Jun 30, 2026 |
| Oakmark Select Fund HARRIS ASSOCIATES INVESTMENT TRUST | 1.5M | $339.7M | 4.08% | Jun 30, 2026 |
| Allspring Special Mid Cap Value Fund ALLSPRING FUNDS TRUST | 1.5M | $329.6M | 2.45% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 1.2M | $283.0M | 0.02% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $250.6M | 0.13% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 1.0M | $232.8M | 0.24% | Jul 31, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 699.8K | $158.7M | 0.23% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 662.6K | $150.3M | 0.02% | Jun 30, 2026 |
| Invesco Small Cap Value Fund AIM Sector Funds (Invesco Sector Funds) | 627.5K | $145.9M | 1.31% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list CRL's shares (CUSIP 159864107), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 4.9M shares10.2%
Sep 8, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 4.9M shares10.2%
Sep 8, 2026 · ↗ - Invesco Ltd.SCHEDULE 13G · passive (13G) · 3.0M shares6.2%
Aug 13, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 4.2M shares8.8%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 4.2M shares8.8%
Aug 6, 2026 · ↗ - Invesco Ltd.SCHEDULE 13G/A · passive (13G) · 2.4M shares4.9%
May 6, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 3.5M shares7.0%
May 6, 2026 · ↗ - FMR LLCSCHEDULE 13G · passive (13G) · 3.5M shares7.0%
May 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming charles river laboratories international as client
- CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q2 · HCR, FOO, PHA$70K
Filing ↗ - CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q1 · HCR, FOO, PHA$70K
Filing ↗ - CAPITOL HILL CONSULTING GROUPCHARLES RIVER LABORATORIES INTERNATIONAL, INC · 2026 Q1 · HCR, FOO, PHA—
Filing ↗ - K&L GATES, LLPCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2021 Q1—
Filing ↗ - K&L GATES, LLPCHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2020 Q4—
Filing ↗
Government Contracts
Federal awards to CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · USAspending
No federal contract awards found for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
U.S. Patents
Recent USPTO applications naming CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
No USPTO patent applications found for CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
Annual Financials
From CRL's 10-K filings · XBRL
No annual XBRL figures on record for CRL. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in CRL's price history.
Material Events (8-K)
Corporate events filed with the SEC
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
From SEC EDGAR company records
Industry (SIC 8731)Services-Commercial Physical & Biological Research
SectorIndustrials
HeadquartersWILMINGTON, MA
SEC CIK0001100682 ↗
Former namesCHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC